AzTrials
AzTrials

Cesarean SectionNCT06952985

Role of Gum Chewing in Post-operative Gut Motility After Cesarean Section

A study testing Sugar free chew gum and Nil Per Oral in people with Cesarean Section and Gum Chewing, run by Dr Maryam Aslam at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Many women deliver by caesarean section nowadays. The proportion of women who deliver by caesarean section ranges from 15% to over 50%, in some countries. After a caesarean section it is common for the bowel to stop working for several hours or days. Read more about this study

Who is it for?
Ages 18 to 40 years, women onlyHealthy volunteers can take part
Conditions the study is for
Cesarean Section, Gum Chewing, Gut Motility
What is being tested?
Sugar free chew gum and Nil Per Oral
Type of treatment
Pill or oral medicine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 sitePakistan
Study dates
1 May 2024to 31 Oct 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Females of age 18-40 years
  • Parity <5
  • Presenting at gestational age ≥ 37 weeks,
  • Undergoing cesarean section (as per operational definition) under spinal anesthesia

Who cannot join

  • Females with history of chronic constipation (medical record)
  • Females with obstructed labour, hypothyroidism (TSH>5IU)
  • Females with intra operative complications such as bowel injury, history of gastrointestinal surgery, and water and electrolyte disturbances (on medical record), abnormal placenta (accrete, increta, previa, abruption)

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • CMH Gujranwala

    Gujranwala, Punjab Province, 52230

Other trials in Pakistan

About this study

Many women deliver by caesarean section nowadays. The proportion of women who deliver by caesarean section ranges from 15% to over 50%, in some countries. After a caesarean section it is common for the bowel to stop working for several hours or days. Although this usually resolves by itself in a few days, it may be very uncomfortable. The retained gases and stools can cause the mother's belly to become swollen and painful with cramps and she may feel nauseated and vomit so she is not able to eat. She may need additional medications to ease these symptoms and her hospital discharge may be delayed. The use of medications that relieve pain during labour and painkillers following the surgery can also delay bowel function. Small intestine activity after abdominal operations returns to normal function within a few hours, gastric activity returns to normal within 24-48 hours, and colon activity returns to normal within 48-72 hours. Due to the delayed motility of the gastrointestinal system in the postoperative period, gas and secretions accumulate in the stomach and small and large intestines, which causes abdominal distension, nausea, vomiting, and pain, all of which negatively affect the comfort level of the patients. Chewing sugar-free gum after cesarean section can promote the early recovery of gastrointestinal function, but the side effects of chewing gum are still unclear, which needs more clinical, large sample and high-quality studies to further verify.

Being tested
Sugar free chew gum, Nil Per Oral

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sugar free chew gumDietary supplement

    Chew gum has a role in ERAS protocol which is significant in early post operative recovery as compared to normal routine care methods

  • Nil Per OralOther

    According to classic protocols patient were kept nil per oral till bowel sounds were audible

Study groups in NCT06952985
Study groupRoleWhat they receive
Group A participants who were given chewing gum 6 hours after the surgery, three times a dayActive comparatorIn group A participants were given chewing gum 6 hours after the surgery, three times a day till passage of flatus
Receives: Dietary Supplement: Sugar free chew gum
Group B participants who were kept nil per oral till bowel sounds were audibleActive comparatorIn group B, participants were managed as per standard routine protocol i.e. allowing oral when gut sound were audible
Receives: Other: Nil Per Oral

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Time of Passage of First flatus

    In group A, females were given chewing gum 6 hours after the surgery, three times a day till passage of flatus. In group B, females were managed as per standard routine protocol i.e. allowing oral when bowel sounds are audible. Mean time of passage of first flatus since procedure was noted in terms of hours.

    Measured: 06 Months

Secondary outcomes (1)
  1. Mean Duration of Hospital Stay

    In both groups mean duration of hospital stay was noted in terms number of days required to stay in the hospital after cesarean. Patients were discharged once they were pain free and on oral medication.

    Measured: 06 Months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 May 2025
  2. Study start1 May 2024
  3. Primary completion31 Oct 2024
  4. Study completion31 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06952985
Sponsor's protocol ID
275
Status last verified
Apr 2025
First submitted
20 Apr 2025
Last updated
1 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Sugar free chew gum and Nil Per Oral in people with Cesarean Section and Gum Chewing, run by Dr Maryam Aslam at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Time of Passage of First flatus (time frame: 06 Months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in